Bulk Manufacturer of Controlled Substances Registration, 8115 [2019-04032]

Download as PDF 8115 Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Notices Company FR docket Patheon API Manufacturing, Inc. .......................................................................................................................... 83 FR 58596 Insys Manufacturing, LLC ..................................................................................................................................... 83 FR 60899 Cayman Chemical Company ................................................................................................................................ 83 FR 60900 Noramco Inc. ........................................................................................................................................................ 83 FR 60898 The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of the listed registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies. Dated: February 18, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–04033 Filed 3–5–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: 27, Notice of registration. 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. Published October 30, 2018. Dated: February 18, 2019. John J. Martin, Assistant Administrator. The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as bulk manufacturer of schedule I and II controlled substances. [FR Doc. 2019–04032 Filed 3–5–19; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: SUMMARY: The company listed below applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted for this notice. Notice of registration. Company FR Docket Organix, Inc ........................................................................... 83 FR 58601 ........................................................................ Jkt 247001 27, The company listed below applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. 83 FR 54611 ........................................................................ 18:35 Mar 05, 2019 27, SUPPLEMENTARY INFORMATION: Insys Manufacturing, LLC ..................................................... VerDate Sep<11>2014 20, The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of schedule I controlled substances. FR Docket The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent November 2018. November 2018. November 2018. November 2018. SUMMARY: Company The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of the listed registrant to manufacture the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR Published with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 Published November 20, 2018. of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and E:\FR\FM\06MRN1.SGM 06MRN1

Agencies

[Federal Register Volume 84, Number 44 (Wednesday, March 6, 2019)]
[Notices]
[Page 8115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04032]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and has been 
granted a registration by the Drug Enforcement Administration (DEA) as 
a bulk manufacturer of schedule I controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as a bulk manufacturer of various basic classes of 
controlled substances. Information on the previously published notice 
is listed in the table below. No comments or objections were submitted 
and no requests for hearing were submitted for this notice.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR Docket                          Published
----------------------------------------------------------------------------------------------------------------
Insys Manufacturing, LLC.................  83 FR 54611.................  October 30, 2018.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of the listed registrant to 
manufacture the applicable basic classes of schedule I and II 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed company.

    Dated: February 18, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-04032 Filed 3-5-19; 8:45 am]
BILLING CODE 4410-09-P